View of Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity

Return to Article Details Liposomal doxorubicin in first line metastatic HER-2-positive breast cancer for prevention the cardiotoxicity Download Download PDF